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ABSTRACT 
Background: Chicken Anemia Virus (CAV) VP3 protein (also known as Apoptin), a basic 
and proline-rich protein has a unique capability in inducing apoptosis in cancer cells but not 
in normal cells. Five truncated Apoptin proteins were analyzed to determine their selective 
ability to migrate into the nucleus of human breast adenocarcinoma MCF-7 cells for inducing 
apoptosis. Methods: For identification of the minimal selective domain for apoptosis, the 
wild-type Apoptin gene had been reconstructed by PCR to generate segmental deletions at 
the N’ terminal and linked with nuclear localization sites (NLS1 and NLS2). All the 
constructs were fused with maltose-binding protein gene and individually expressed by in 
vitro Rapid Translation System. Standardized dose of proteins were delivered into human 
breast adenocarcinoma MCF-7 cells and control human liver Chang cells by cytoplasmic 
microinjection, and subsequently observed for selective apoptosis effect. Results: Three of 
the truncated Apoptin proteins with N-terminal deletions spanning amino acid 32–83 retained 
the cancer selective nature of wild-type Apoptin. The proteins were successfully translocated 
to the nucleus of MCF-7 cells initiating apoptosis, whereas non-toxic cytoplasmic retention 
was observed in normal Chang cells. Whilst these truncated proteins retained the tumour-
specific death effector ability, the specificity for MCF-7 cells was lost in two other truncated 
proteins that harbor deletions at amino acid 1–31. The detection of apoptosing normal Chang 
cells and MCF-7 cells upon cytoplasmic microinjection of these proteins implicated a loss in 
Apoptin’s signature targeting activity. Conclusions: Therefore, the critical stretch spanning 
amino acid 1–31 at the upstream of a known hydrophobic leucine-rich stretch (LRS) was 
strongly suggested as one of the prerequisite region in Apoptin for cancer targeting. 
Identification of this selective domain provides a platform for developing small targets to 
facilitating carrier-mediated-transport across cellular membrane, simultaneously promoting 
protein delivery for selective and effective breast cancer therapy.  
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